173 related articles for article (PubMed ID: 32743766)
21. Low Prevalence of TERT Promoter, BRAF and RAS Mutations in Papillary Thyroid Cancer in the Greek Population.
Argyropoulou M; Veskoukis AS; Karanatsiou PM; Manolakelli A; Kostoglou-Athanassiou I; Vilaras G; Karameris A; Liadaki K
Pathol Oncol Res; 2020 Jan; 26(1):347-354. PubMed ID: 30361901
[TBL] [Abstract][Full Text] [Related]
22. An Extremely Rare Case of Poorly Differentiated Thyroid Carcinoma Arising in Malignant Struma Ovarii and Concurrent Papillary Thyroid Carcinoma: A Case Study.
Harrison JC; Figh M; Shah H
Cureus; 2023 Aug; 15(8):e44481. PubMed ID: 37791194
[TBL] [Abstract][Full Text] [Related]
23. Malignant struma ovarii harboring a unique NRAS mutation: case report and review of the literature.
Gobitti C; Sindoni A; Bampo C; Baresic T; Giorda G; Alessandrini L; Canzonieri V; Franchin G; Borsatti E
Hormones (Athens); 2017 Jul; 16(3):322-327. PubMed ID: 29278520
[TBL] [Abstract][Full Text] [Related]
24. Struma ovarii with atypical features and synchronous primary thyroid cancer: a case report and review of the literature.
Siegel MR; Wolsky RJ; Alvarez EA; Mengesha BM
Arch Gynecol Obstet; 2019 Dec; 300(6):1693-1707. PubMed ID: 31679038
[TBL] [Abstract][Full Text] [Related]
25. Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions.
Ballester LY; Sarabia SF; Sayeed H; Patel N; Baalwa J; Athanassaki I; Hernandez JA; Fang E; Quintanilla NM; Roy A; López-Terrada DH
Pediatr Dev Pathol; 2016; 19(2):94-100. PubMed ID: 26366474
[TBL] [Abstract][Full Text] [Related]
26. Single Point Mutations in Pediatric Differentiated Thyroid Cancer.
Alzahrani AS; Murugan AK; Qasem E; Alswailem M; Al-Hindi H; Shi Y
Thyroid; 2017 Feb; 27(2):189-196. PubMed ID: 27824297
[TBL] [Abstract][Full Text] [Related]
27. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).
Carta C; Moretti S; Passeri L; Barbi F; Avenia N; Cavaliere A; Monacelli M; Macchiarulo A; Santeusanio F; Tartaglia M; Puxeddu E
Clin Endocrinol (Oxf); 2006 Jan; 64(1):105-9. PubMed ID: 16402937
[TBL] [Abstract][Full Text] [Related]
28. Thyrotoxic adenoma followed by atypical hyperthyroidism due to struma ovarii: clinical and genetic studies.
Ciccarelli A; Valdes-Socin H; Parma J; Khoo SK; Schoumans J; Colao A; Hamoir E; Beckers A
Eur J Endocrinol; 2004 Apr; 150(4):431-7. PubMed ID: 15080771
[TBL] [Abstract][Full Text] [Related]
29. Application of BRAF, NRAS, KRAS mutations as markers for the detection of papillary thyroid cancer from FNAB specimens by pyrosequencing analysis.
Park SJ; Sun JY; Hong K; Kwak JY; Kim EK; Chung WY; Choi JR
Clin Chem Lab Med; 2013 Aug; 51(8):1673-80. PubMed ID: 23585181
[TBL] [Abstract][Full Text] [Related]
30. BRAF and RAS Mutational Status in Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Invasive Subtype of Encapsulated Follicular Variant of Papillary Thyroid Carcinoma in Korea.
Kim M; Jeon MJ; Oh HS; Park S; Kim TY; Shong YK; Kim WB; Kim K; Kim WG; Song DE
Thyroid; 2018 Apr; 28(4):504-510. PubMed ID: 29439609
[TBL] [Abstract][Full Text] [Related]
31. Mutational analysis using next generation sequencing in pediatric thyroid cancer reveals BRAF and fusion oncogenes are common.
Newfield RS; Jiang W; Sugganth DX; Hantash FM; Lee E; Newbury RO
Int J Pediatr Otorhinolaryngol; 2022 Jun; 157():111121. PubMed ID: 35397361
[TBL] [Abstract][Full Text] [Related]
32. Papillary Thyroid Cancer in a Struma Ovarii in a 17-Year-Old Nulliparous Patient: A case Report.
Gonet A; Ślusarczyk R; Gąsior-Perczak D; Kowalik A; Kopczyński J; Kowalska A
Diagnostics (Basel); 2020 Jan; 10(1):. PubMed ID: 31952290
[No Abstract] [Full Text] [Related]
33. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
34. Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China.
Huang M; Yan C; Xiao J; Wang T; Ling R
Diagn Pathol; 2019 Jul; 14(1):74. PubMed ID: 31300059
[TBL] [Abstract][Full Text] [Related]
35. Highly differentiated follicular carcinoma arising from struma ovarii: a report of 3 cases, a review of the literature, and a reassessment of so-called peritoneal strumosis.
Roth LM; Karseladze AI
Int J Gynecol Pathol; 2008 Apr; 27(2):213-22. PubMed ID: 18317221
[TBL] [Abstract][Full Text] [Related]
36. Papillary carcinoma arising in struma ovarii versus ovarian metastasis from primary thyroid carcinoma: a case report and review of the literature.
Leite I; Cunha TM; Figueiredo JP; Félix A
J Radiol Case Rep; 2013 Oct; 7(10):24-33. PubMed ID: 24421920
[TBL] [Abstract][Full Text] [Related]
37. Whole-Genome and Segmental Homozygosity Confirm Errors in Meiosis as Etiology of Struma Ovarii.
Henderson BB; Chaubey A; Roth LM; Robboy SJ; Tarasidis G; Jones JR; Sundermann JM; Chou J; Craddock AL; Stevenson L; Friez MJ; Kincaid EH; Stevenson RE
Cytogenet Genome Res; 2020; 160(1):2-10. PubMed ID: 31865307
[TBL] [Abstract][Full Text] [Related]
38. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases.
Devaney K; Snyder R; Norris HJ; Tavassoli FA
Int J Gynecol Pathol; 1993 Oct; 12(4):333-43. PubMed ID: 8253550
[TBL] [Abstract][Full Text] [Related]
39. Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics.
Xu B; Tuttle RM; Sabra MM; Ganly I; Ghossein R
Thyroid; 2017 May; 27(5):632-640. PubMed ID: 28049366
[TBL] [Abstract][Full Text] [Related]
40. Malignant struma ovarii: surgical, histopathological and survival outcomes for thyroid-type carcinoma of struma ovarii with recommendations for standardising multi-modal management. A retrospective case series sharing the experience of a single institution over 10 years.
Addley S; Mihai R; Alazzam M; Dhar S; Soleymani Majd H
Arch Gynecol Obstet; 2021 Apr; 303(4):863-870. PubMed ID: 33512594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
